Effect of a 4-week treatment with theophylline on sputum eosinophilia and sputum eosinophil chemotactic activity in steroid-naive asthmatics

Clinical and Experimental Allergy

Volumn 30, Issue 8, 2000, Pages 1151-1160

  Louis, R ^a   Bettiol, J ^a   Cataldo, D ^a   Sele, J ^a   Henquet, M ^a   Radermecker, M ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

Asthma; Chemotaxis; Eosinophils; Sputum; Theophylline

Indexed keywords

EOSINOPHIL CATIONIC PROTEIN; STEROID; THEOPHYLLINE; UNAIR R;

ADULT; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; ASTHMA; CHEMOTAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG SALIVA LEVEL; DRUG TOLERABILITY; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; LUNG FUNCTION; MALE; PRIORITY JOURNAL; PROVOCATION TEST; RANDOMIZED CONTROLLED TRIAL; SPUTUM ANALYSIS;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BLOOD PROTEINS; CELL COUNT; CHEMOTAXIS, LEUKOCYTE; DOUBLE-BLIND METHOD; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; HUMANS; LUNG; MALE; MIDDLE AGED; PLACEBOS; PULMONARY EOSINOPHILIA; RIBONUCLEASES; SPUTUM; THEOPHYLLINE;

EID: 0033862177     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2000.00867.x     Document Type: Article

References (38)

1. 1 Weinberger M, Hendeles L. Theophylline in asthma. N Engl J 1996; 334:1380-8.
2. 2 Piafsky KM, Ogilvie RI. Dosage of theophylline in bronchial asthma. N Engl J Med 1975; 292:1218-22.
3. 3 Aubier M, De Troyer A, Sampson M, Macklem PT, Roussos C. Aminophylline improves diaphragmatic contractility. N Engl J Med 1981; 305:249-52.
4. 4 Barnes PJ, Pauwels RA. Theophylline in the management of asthma: time for reappraisal? Eur Respir J 1994; 7:579-91.
5. 5 Djukanovic R, Roche W, Wilson J, Beasley R, Twentymann O, Howarth P et al. Mucosal inflammation in asthma. Am Rev Respir Dis 1990; 142:434-57.
6. 6 Gleich G. The eosinophil in asthma: current understanding. J Allergy Clin Immunol 1990; 85:422-36.
7. 7 Adelroth E, Barnes N, Chung K, Davies R, Poulter L. Drug Trials. Eur Respir J 1998; 11 (Suppl.) 26:36-8.
8. 8 Pauwels R, van Renterghem D, Van der Straeten M, Johannsson N, Persson CGA. The effect of theophylline and enprofylline on allergen-induced bronchoconstriction. J Allergy Clin Immunol 1985; 76:583-90.
9. 9 Mapp C, Boshetto P, Dal Veccho L, Crescioli S, de Marzo N, Paleari D et al. Protective effect of anti-asthma drugs on late asthmatic reactions and increased airway responsiveness induced by toluene diisocyanate in sensitized subjects. Am Rev Respir Dis 1987; 136:1403-7.
10. 10 Crescioli S, Spinazzi A, Plebani M, Pozzani M, Mapp C, Boschetto P et al. Theophylline inhibits early and late asthmatic reactions induced by allergens in asthmatic subjects. Ann Allergy 1991; 66:245-51.
11. 11 Jaffar ZH, Sullivan P, Page C, Costello J. Low-dose theophylline modulates T-lymphocyte activation in allergen-challenged asthmatics. Eur Respir J 1996; 9:456-62.
12. 12 Sullivan P, Bekir S, Jaffar Z, Page C, Jeffery P, Costello J. Anti-inflammatory effects of low-dose oral theophylline in asthma. Lancet 1994; 343:1006-8.
13. 13 Kidney J, Dominguez M, Taylor PM, Rose M, Chung KF, Barnes PJ. Immunomodulation by theophylline in asthma. Demonstration by withdrawal of therapy. Am J Respir Crit Care Med 1995; 151:1907-14.
14. 14 Finnerty JP, Lee C, Wilson S, Madden J, Djukanovic R, Holgate ST. Effects of theophylline on inflammatory cells and cytokines in asthmatic subjects: a placebo-controlled parallel group study. Eur Respir J 1996; 9:1672-7.
15. 15 Pin I, Gibson R, Kolendowicz A, Girgis-Gabardo Denburg J, Hargreave F et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax 1992; 47:25-9.
16. 16 Fahy J, Liu J, Wong H, Boushey H. Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. Am Rev Respir Dis 1993; 147:1126-31.
17. 17 Kips J, Fahy J, Hargreave F, Ind P, in't Veen J. Methods for sputum induction and analysis of induced sputum: a method for assessing airway inflammation in asthma. Eur Respir J 1998; 11 (Suppl.) 26:9-12.
18. 18 Louis R, Shute J, Biaggi S, Stanciu L, Marelli F, Tenor H et al. Cell infiltration, ICAM-1 expression and eosinophil chemotactic activity in asthmatic sputum. Am J Respir Crit Care Med 1997; 155:466-72.
19. 19 Jolley M, Stroupe S, Schwenzer Wang C, Lu-Steffes Hill D, Popelka S, Holen J, Kelso D. Fluoresence polarization immunoassay (FPIA) for theophylline; clinical correlation and reagent stability. Clin Chem 1981; 27:1575-9.
20. 20 Cockcroft DW, Killian DN, Mellon JJ, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7:235-43.
21. 21 Louis R, Bury Th, Corhay JL, Radermecker M. No increase in plasma histamine during PAF-induced airway obstruction in allergic asthmatics. Chest 1993; 104:806-10.
22. 22 Hatzelmann A, Tenor H, Schudt C. Differential effects of nonselective and selective phosphodiesterase inhibitors on human eosinophil function. Br J Pharmacol 1995; 114:821-31.
23. 23 Claman D, Boushey H, Liu J, Wong H, Fahy J. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994; 94:861-9.
24. 24 Reed C, Offord K, Nelson H, Li J, Tinkelman D and the American Academy of Allergy, Asthma and Immunology BeclomethasoneDipropionate-Theophylline Study Group. Aerosol beclomethasone dipropionate spray compared with theophylline as primary treatment for chronic mild to moderate asthma. J Allergy Clin Immunol 1998; 101:14-23.
25. 25 Tenor H, Hatzelman A, Church M, Schudt C, Shute J. Effects of theophylline and rolipram on leukotriene C4 (LTC4) synthesis and chemotaxis of human eosinophils from normal and atopic subjects. Br J Pharmacol 1996; 118:1727-35.
26. 26 Kraft M, Torwick J, Trudeau J, Wenzel S, Martin R. Theophylline: potential anti-inflammatory effects in nocturnal asthma. J Allergy Clin Immunol 1996; 97:1242-6.
27. 27 Ohta K, Sawamoto S, Nakajima M, Kubota S, Tanaka Y, Miyasaka T et al. The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis. Clin Exp Allergy 1996; 26:10-5.
28. 28 Efthimiadis A, Pizzichini M, Pizzichini E, Dolovich J, Hargreave F. Induced sputum cell and fluid-phase indices of inflammation: comparison of treatment with dithiothreitol vs phosphate-buffered saline. Eur Respir J 1997; 10:1336-40.
29. 29 Louis R, Shute J, Goldring Perks B, Lau LCK, Radermecker M, Djukanovic R. The effect of processing on inflammatory markers in induced sputum. Eur Respir J 1999; 13:660-7.
30. 30 Dutoit J, Salome C, Woolcock A. Inhaled corticosteroids reduce the severity of bronchial hyperresponssiveness in asthma but oral theophylline does not. Am Rev Respir Dis 1987; 136:1174-8.
31. 31 Kirby J, Hargreave F, Gleich J, O'Byrne P. Bronchoalveolar cell profiles in asthmatic and non asthmatic subjects. Am Rev Respir Dis 1987; 136:379-83.
32. 32 Wardlaw A, Dunnette S, Gleich G, Collins J, Kay B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Am Rev Respir Dis 1988; 137:62-9.
33. 33 Fergusson A, Wong H. Bronchial hyperresponsiveness in asthmatic children: correlation with macrophages and eosinophils in bronchoalveolar lavage fluid. Chest 1989; 96:988-91.
34. 34 Crimi E, Spanavello A, Neri M, Ind P, Rossi G, Brusasco V. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998; 157:4-9.
35. 35 Gibson P, Denburg J, Dolovich J, Ramsdale E. Chronic cough: eosinophilic bronchitis without asthma. Lancet 1989; 1:1346-8.
36. 36 Louis E, Louis R, Shute J, Lau L, Franchimont D, Lamproye A et al. Bronchial eosinophilic infiltration in Crohn's disease in the absence of pulmonary disease. Clin Exp Allergy 1999; 29:660-7.
37. 37 Uchida D, Ackerman S, Coyle A, Larsen G, Weller P, Freed J et al. The effect of human eosinophil granule major basic protein on airway responsiveness in the rat in vivo. A comparison with polycations. Am Rev Respir Dis 1993; 147:982-8.
38. 38 Fahy J, Boushey H. Effect of low-dose beclomethasone dipropionate on asthma control and airway inflammation. Eur Respir J 1998; 11:240-1247.